Anand V Ramanathan, MD
Disclosures: Nothing to disclose
CURRICULUM VITAE

CURRICULUM VITAE, Page 1.

ANAND V. RAMANATHAN, M.D.

 

 

CURRICULUM VITAE

 

ANAND V. RAMANATHAN, M.D.

 

 

Home Address:              1388 Urban Drive

              Darien, Illinois  60561

                                                                     

Office Address:              Midwest Heart Foundation               Midwest Heart Specialists office              Immediate Past Address:

              1919 S. Highland Avenue              Edward Cardiovascular Institute               Midwest Heart Specialists

              Building B ; Suite 201              801 S. Washington St.-4th Floor              120 Spalding, Suite 206             

              Lombard, Illinois  60148              Naperville, Illinois  60540              Naperville, Illinois  60540              telephone:  630/932-2165              telephone:  630/527-2730

              telefax:  630/268-9609

 

Date of Birth:              June 27, 1967

 

Citizenship:              U.S.A.

 

Marital Status:              Married

 

Education:

 

1988  B.S.               University of North Carolina, Chapel Hill, North Carolina

                            B. S. Chemistry with Honors

             

1992  M.D.              University of North Carolina, Chapel Hill, North Carolina

 

 

Postgraduate Training and Fellowship Appointments:

 

1992-1995              Resident in Internal Medicine, Washington University/Barnes Hospital, St. Louis, Missouri

 

1995-1998              Fellow in General Cardiology, Baylor College of Medicine, Houston, Texas

 

1998-1999              Fellow in Interventional Cardiology, Baylor College of Medicine, Houston, Texas

 

2003                            Fellow in Cardiovascular Magnetic Resonance Imaging, Washington University, St. Louis, Missouri, Level II

 

 

Licensure and Board Certification:

 

1995-present              Texas Medical Licensure

1999-present              Illinois Medical Licensure                            036-100269


Licensure and Board Certification (continued):

 

1995                            American Board of Internal Medicine

                               Certificate #163804

 

1998                            American Board of Internal Medicine, Subspecialty Board of Cardiovascular Diseases

                               Certificate #163804 

 

1999                            American Board of Internal Medicine, Added Qualifications in Interventional Cardiology

                                Certificate #163804

                           

 

Honors and Awards:

 

Phi Eta Sigma Honor Society

Merck Index Award for Excellence in Chemistry, 1988

Honor’s Thesis, 1988

Foreign Fellowship Research Award, 1989

NIH Research Grant, 1989

 

 

Society Membership:

 

American Medical Association

American College of Cardiology              Fellowship status:  08/31/01

Houston Cardiology Society

Society for Cardiac Angiography and Interventions (SCA&I)

 

 

Hospital Appointments:

 

1999-present              Consulting Cardiologist:

                            Edward Hospital, Naperville, Illinois

                            Central DuPage Hospital, Winfield, Illinois

                            Good Samaritan Hospital, Downers Grove, Illinois

                            Elmhurst Memorial Hospital, Elmhurst, Illinois

                           

 

Research Experience:

 

Platelet GPIIb/IIIa receptors: 

  • Reversal of the Platelet Effects of Abciximab
  • Effectiveness of Dosing Abciximab in Emergency  Versus Planned Interventions
  • Meta-analysis of Diabetics and GPIIb/IIIa Inhibitors
  • Expression of Platelet Derived Micro-particles in Diabetics After Coronary Intervention and Abciximab Administration

Research Experience (continued):

 

Principal Investigator

A Prospective, Randomized, Open-Label, Multicenter Study in Patients Presenting with Acute Coronary Syndromes (ACS).  Aventis Pharmaceuticals

Protocol Number ENO.GMA.301.  IND# 31532

 

Sub-Investigator

A Randomized, Open-Label, Multicenter Pilot Study Evaluating the Safety and Efficacy of Pharmacomechanical Thrombolysis Combined with GPIIb/IIIa Inhibition in Acute Myocardial Infarction

 

Sub-Investigator

TAXUS ARRIVE 2: Multi-Center Safety Surveillance Program

 

Sub-Investigator

“A Phase 2, Multicenter, Double-Blind, Placebo-Controlled, Dose- Ranging Study to Evaluate the Safety and Efficacy of BO-653 in Prevention of Post-Angioplasty Restonosis in stented Lesions.”

 

Original Publications/Abstracts/Presentations:

 

1.     Ramanathan A, Harrison W:  Further characterization of ALDH III.  Honor’s Thesis, University of North Carolina, 1988

 

2.     Guest T, Ramanathan A, Teuter P, et al:  Myocardial injury critically ill patients.  JAMA 273:1945-1949, 1995.

 

3.     Blaustein A, Ramanathan A, Zogbhi W:  Tricuspid valve disease.  Cardiology Clinics 16(3):551-72, 1998.

 

4.     Ramanathan A, Kleiman N:  Review of GPIIb/IIIa inhibitors and angioplasty.  Indian Heart Journal 50 (Suppl 1):45-56, 1998.

 

5.     Ramanathan A, Miller DP, Kleinman N:  Effects of GPIIb-IIIa antagonists in patients with diabetes:  A meta-analysis.  Abstract presentation, American College of Cardiology, 1999.

 

6.              Isaac JC, Trenth MG, Ramanathan AV, et al:  The effect of drug affinity on reversal of glycoprotein IIb/IIIa antagonists using platelet transfusion.  Abstract presentation, American College of Cardiology, 2000.

 

7.              Clark SE, Stephan WJ, Ramanathan AV, et al:  Percutaneous catheter-based septal closure using transesophageal echocardiography and conscious sedation.  Catheter Cardiovasc Interventions, B-16, May 2003.  Poster presentation, the 26th Annual Scientific Sessions of the Society for Cardiac Angiography and Intervention, Boston, Massachusetts, May 2003.